Experimental studies have shown that endothelium-restricted inhibition of NF-κB activation, including ablation of NEMO, resulted in significantly reduced atherosclerotic plaque formation in mice52 and that ablation of NEMO in smooth muscle cells (SMC) inhibited high-fat diet-induced atherosclerosis in mice53. This evidence concerns the gene NFKB1 and atherosclerosis.